X2KH3D9
Bypass Femoral Artery, Right to New Technology Group 9 with Conduit through Femoral Vein to Superficial Femoral Artery, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | 2 Cardiovascular System |
| Operation | K Bypass |
| Body Part | H Femoral Artery, Right |
| Approach | 3 Percutaneous |
| Device | D Conduit through Femoral Vein to Superficial Femoral Artery |
| Qualifier | 9 New Technology Group 9 |
Operation Definition
Altering the route of passage of the contents of a tubular body part
Procedure Overview
This family covers rerouting blood flow around a diseased or blocked vessel using a new technology conduit or device not yet captured by standard bypass codes. Traditional coronary or peripheral bypass uses a harvested vein or synthetic graft; procedures in this group involve a novel material or delivery method that has been granted distinct New Technology status, such as an engineered conduit designed to improve long-term patency. The clinical goal remains the same as any bypass: restoring adequate blood supply to tissue starved by an obstruction.
Patients undergoing these procedures are often part of a defined population where the newer conduit or technique has shown a specific advantage, such as reduced graft failure, over conventional grafting materials.
Anatomy & Axis Detail
Femoral Artery, Right
The right femoral artery is the principal inflow vessel supplying the right lower extremity and a frequent site of severe peripheral arterial disease. When Bypass is documented under New Technology for this body part, it generally reflects use of a bioengineered or otherwise novel conduit material to reroute blood flow around an occluded segment, particularly in patients lacking usable autologous vein or facing an infected or hostile surgical field where conventional synthetic grafts carry higher risk. This body part value may also apply to catheter-based deep venous arterialization techniques used for critical limb ischemia when no distal arterial target remains for a conventional bypass. Accurate coding depends on identifying the specific graft material or device driving the New Technology designation.
Approach: Percutaneous
In New Technology, Percutaneous describes entry into the body via needle or instrument puncture through the skin or a mucous membrane, without a surgical incision, mirroring the same concept in Medical and Surgical. It is distinguished from Open access, which requires a full incision, and from Percutaneous Endoscopic, which adds visualization through the puncture site.
Device / Substance / Technology: Conduit through Femoral Vein to Superficial Femoral Artery
This value describes a device conduit routed from the femoral vein to the superficial femoral artery, most relevant to percutaneous arteriovenous fistula creation for hemodialysis access. It is distinguished from the femoral vein to popliteal artery conduit by the specific arterial segment connected, which affects fistula location and downstream vascular anatomy. The value documents the anatomic pathway rather than the device performing the connection.
Qualifier: New Technology Group 9
Group 9 is the seventh-position qualifier used in the New Technology section to mark a device, substance, or technique as belonging to the 2022 annual cohort of new technology add-on codes. It has no clinical meaning of its own beyond that vintage tag, so coders rely on the specific table and body system to know what procedure it applies to. It is distinguished from Group 8 and Group 10 purely by the fiscal year the technology was approved for separate identification.
Coding & Documentation
Coders must confirm the operative report names the specific device or conduit listed in the New Technology reference table, along with the two body parts connected by the bypass, since the code identifies both the origin and the route of the rerouted flow. A frequent assignment error is selecting the standard section Bypass code when the graft material actually qualifies for New Technology designation, or reversing the coded direction of blood flow described in the qualifier. Documentation should also clearly distinguish a true bypass, which creates an alternate route while leaving the diseased segment in place, from removal or replacement of the diseased segment itself.
Commonly Confused With
This family is frequently confused with standard Cardiovascular Bypass procedures, where the deciding factor is exclusively whether the conduit or device is included in the current New Technology table. It also differs from Replacement, since a bypass leaves the original diseased vessel in place and adds an alternate route rather than substituting the vessel's structure.